Adam Vogel

Adam Vogel is the Chief Executive Officer of Redenlab, a neuroscience technology company specializing in speech and language biometrics for clinical trials, since December 2016. Additionally, Adam serves as an Adjunct Professor at Monash University in the Department of Neuroscience and has been a Professor at the University of Melbourne since November 2010, focusing on speech, language, and swallowing deficits in neurological conditions. Adam is a Research Associate at the Murdoch Children's Research Institute, a Consultant Speech Pathologist at the National Ataxia Telangiectasia Clinic, and a Speech Pathologist at Monash Health. Further roles include Honorary Clinical Research Fellow at the Bionics Institute and Consultant Speech Pathologist at the Eastern Cognitive Disorders Clinic. Adam's academic credentials include a PhD in Neuroscience and degrees in Speech Pathology and Psychology from the University of Melbourne and The University of Queensland.